Angelika Gründling is a Professor in Molecular Microbiology at Imperial College London, where she started her independent research career in 2007. The research focuses onthe investigation of fundamental processes that are essential for the growth of Gram-positive bacterial pathogens. She combines genetic, biochemical and in collaborations structural approaches to provide mechanistic insight into cell wall synthesis and nucleotide signalling pathways in Staphylococcus aureus and Listeria monocytogenes.Angelika obtained her Ph.D. in Microbiology from the University of Vienna in 2000. She performed her postdoctoral training at the Harvard Medical School, where she investigated flagallar motility in the bacterial pathogen Listeria monocytogenes and at the University of Chicago, where she initiated her studies on the cell wall of S. aureus. At Imperial College London she continues her work on the bacterial cell wall and more recently on the essential signalling nucleotide c-di-AMP.
Gründling A, Ji Q, Salipante SJ, 2023, Using CRISPR-Cas9-Based Methods for Genome Editing in Staphylococcus aureus., Cold Spring Harb Protoc
et al., 2022, Imbalance of peptidoglycan biosynthesis alters the cell surface charge of Listeria monocytogenes, The Cell Surface, Vol:8, ISSN:2468-2330, Pages:1-16
et al., 2022, Purine nucleosides interfere with c-di-AMP levels and act as adjuvants to re-sensitise MRSA to β-lactam antibiotics
et al., 2022, Structure-based discovery of lipoteichoic acid synthase inhibitors., Journal of Chemical Information and Modeling, Vol:62, ISSN:1549-9596, Pages:2586-2599